Home > Financial Ratios > VAISHALI PHARMA

VAISHALI PHARMA
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for VAISHALI PHARMA
Please provide your vote to see the results

VAISHALI PHARMA Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 46.0243.5414.3510.2811.55

What is the latest EV/Core EBITDA ratio of VAISHALI PHARMA ?

The latest EV/Core EBITDA ratio of VAISHALI PHARMA is 46.02 based on Mar2025 Standalone results.
Year EV/Core EBITDA
Mar202546.02
Mar202443.54
Mar202314.35
Mar202210.28
Mar202111.55

How is EV/Core EBITDA of VAISHALI PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2025 46.02
5.70
Mar2024 43.54
203.41
Mar2023 14.35
39.59
Mar2022 10.28
-11.00
Mar2021 11.55 -

Other Financial Ratios of VAISHALI PHARMA


Compare EV/Core EBITDA ratio of peers of VAISHALI PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VAISHALI PHARMA ₹86.4 Cr -8.4% -16.4% -52.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹431,628.0 Cr -0.1% 4.7% 6.2% Stock Analytics
DIVIS LABORATORIES ₹167,975.0 Cr -1.7% 2.5% 12.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,804.0 Cr -1.1% 7.6% 45.4% Stock Analytics
DR REDDYS LABORATORIES ₹108,829.0 Cr -0.4% 6.3% 14.7% Stock Analytics
CIPLA ₹106,768.0 Cr -2.3% 0.3% -8.9% Stock Analytics


VAISHALI PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VAISHALI PHARMA

-8.4%

-16.4%

-52.7%

SENSEX

-2.8%

-2%

7.3%


You may also like the below Video Courses